Karolinska Development
An investment company that finances and supports innovative life science ventures.
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
Description
Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2014-12-04 16:49 |
Karolinska Developments extra bolagsstämma
|
Swedish | 285.2 KB | ||
| 2014-12-04 16:49 |
Karolinska Development’s Extraordinary General Meeting
|
English | 285.7 KB | ||
| 2014-12-03 07:30 |
Karolinska Development offentliggör åtaganden och avsikter att stödja de föresl…
|
Swedish | 305.3 KB | ||
| 2014-11-12 08:30 |
Optionsrätt med Athera kommer inte att utnyttjas efter förändring av Boehringer…
|
Swedish | 290.8 KB | ||
| 2014-11-12 08:30 |
The option rights with Athera will not be exercised due to re-evaluation of Boe…
|
English | 291.6 KB | ||
| 2014-11-05 09:35 |
Karolinska Development secures funding from CP Group, a leading Asian life scie…
|
English | 317.1 KB | ||
| 2014-11-05 09:35 |
Karolinska Development säkrar finansiering från CP Group, en ledande asiatisk l…
|
Swedish | 314.5 KB | ||
| 2014-10-22 08:00 |
Forendo Pharma slutför finansiering som tillför 12 miljoner euro för utveckling…
|
Swedish | 300.3 KB | ||
| 2014-10-22 08:00 |
Forendo Pharma closes EUR 12 million Series A financing round to develop a nove…
|
English | 290.3 KB | ||
| 2014-10-21 08:00 | Swedish | 545.9 KB | |||
| 2014-10-21 08:00 | English | 648.6 KB | |||
| 2014-10-21 07:45 |
Athera initiates Phase I trial with its fully human antibody PC-mAb
|
English | 289.4 KB | ||
| 2014-10-21 07:45 |
Athera inleder fas I-studie med bolagets humana antikropp PC-mAb
|
Swedish | 288.1 KB | ||
| 2014-10-20 08:38 |
OssDsigns Cranioplug får marknadsgodkännande i USA
|
Swedish | 286.2 KB | ||
| 2014-10-20 08:38 |
OssDsign’s Cranioplug receives marketing approval in the US
|
English | 377.2 KB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karolinska Development
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
Peer Companies
